Skip to main content

People in the News: George Church, Helmy Eltoukhy, AmirAli Talasaz, Michael Wiley

Premium

Pathway Genomics has appointed George Church to its scientific advisory board. Church is a professor of genetics at Harvard Medical School, director of the Harvard NHGRI Center of Excellence in Genomic Science, and founder of the Personal Genome Project.


Startup Guardant Health, which is developing a targeted NGS-based test that assesses circulating tumor DNA, has disclosed members of its management.

Helmy Eltoukhy is cofounder and CEO. Eltoukhy joined Guardant Health from Illumina, where he served in a number of positions, including most recently as senior director of Illumina's advanced technology group. Previously, he was founder and CEO of Avantome and a postdoctoral fellow at Stanford University's Genome Technology Center.

AmirAli Talasaz is cofounder and CTO of Guardant Health. He also joins the company from Illumina, where he was most recently senior director of scientific research. Previously, he was cofounder of Auriphex Biosciences and was also a research associate at Stanford University's Genome Technology Center.

Michael Wiley is Guardant Health's CFO. Previously, he was CFO at Voyage Medical and also served as VP of finance at Microchip Biotechnologies.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.